Drug Injury Attorney Blog

Recent Posts from Drug Injury Attorney Blog

• FDA Calls for New Labeling for Anesthetics Used in Post-Surgery Pain Pumps

  As a St. Louis defective drug attorney, I was disturbed to read about a new Food and Drug Administration warning of potential irreversible cartilage damage from certain anesthetics and medical devices. According to a Nov.…

• Study Confirms Serious Blood Clot Threat From Anemia Drugs for Cancer Patients

  As a defective prescription drug attorney, I am familiar with at least one older study linking a class of anemia drugs to potentially life-threatening blood clots. On Nov. 10, a study to be published in…

• Gadolinium Lawsuit Against GE Filed in St. Louis Circuit Court

  General Electric, GE Healthcare AS and other entities, alleging she developed Nephrogenic Systemic Fibrosis (NSF) as a result of being given gadolinium-based contrast agents – or GBCAs – for magnetic resonance imaging (MRI) and magnetic…

• Diabetes Drug Prescribing Information Revised to Reflect Reports of Kidney Problems

  As a pharmaceutical liability attorney, I have noticed several reports of serious safety problems with the newest drugs intended for treatment of Type II diabetes. So I was disappointed, but not entirely surprised, to see…

• European Regulators Review Arthritis Drug Safety as FDA Announces New Case of Brain Infection

  Back in April, I wrote on this blog about the withdrawal of the drug Raptiva (efalizumab) from the market for safety reasons. That medication, intended for treating psoriasis, was implicated for weakening the immune system…

• Suspected Defects in Power Cords for Medical Devices Spark FDA Investigation

  The U.S. Food and Drug Administration is investigating possible defects in power cords used with medical devices from at least two companies, Reuters reported Oct. 19. Abbott Nutrition, a division of Abbott Laboratories Inc., and…

• FDA System for Tracking and Announcing Medical Device Recalls Faulted as Recalls Soar

  As a defective medical device attorney, I was alarmed to read a detailed article on medical device recall problems from the Associated Press Oct. 5. In short, the article exposes the federal government’s dangerous lack…

• FDA Warns Doctors and Parents About Dosage Discrepancy for Liquid Form of Tamiflu

  As a dangerous drug attorney, I was very interested to see a series of warnings from the U.S. Food and Drug Administration about the drug Tamiflu. Tamiflu (oseltamivir) is an antiviral drug that fights the…

• FDA Orders Black Box Warning for Injected Sedative at Center of Supreme Court Case

  Nearly seven months after the drug Phenergan was the center of a controversial U.S. Supreme Court ruling, the Food and Drug Administration has required a black box warning for the label of its generic version,…

• Memo Introduced at Paxil Trial Suggests Drug Company May Have Buried Negative Studies

  Pharmaceutical company GlaxoSmithKline discussed burying studies linking antidepressant Paxil (paroxetine) to birth defects, Bloomberg News reported Sept. 15. The revelation came in the opening phases of a lawsuit against GlaxoSmithKline by Michelle David and her…